Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
about
Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersOnabotulinumtoxinA for trigeminal neuralgia: a review of the available dataTemporomandibular Myofacial Pain Treated with Botulinum Toxin InjectionDevelopment of onabotulinumtoxinA for chronic migraineTreating tension-type headache -- an expert opinion.Botulinum toxin type a for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trialThe importance of placebo in headache research.Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group studyOnabotulinumtoxinA for chronic migraine: a critical appraisal.Tension type headache.The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headacheMigraine: emerging treatment options for preventive and acute attack therapy.Investigating prophylactic botulinum toxin type A for chronic headache disorders.Is there hope for chronic pain and headache?Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache.Pharmacotherapy of tension-type headache (TTH).Migraine treatment and placebo effect.Botulinum Toxin in Migraine Treatment.Treatment of chronic migraine.Treatment of refractory pain with botulinum toxins--an evidence-based review.Botulinum toxin and the treatment of headache: a clinical review.Muscle trigger point therapy in tension-type headache.Emerging treatment for chronic migraine and refractory chronic migraine.Current and investigational drugs for the prevention of migraine in adults and children.Update of chronic tension-type headache.Application of botulinum toxin in pain management.Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A ReviewOnabotulinum toxin a for the treatment of headache in service members with a history of mild traumatic brain injury: a cohort study.Comparison of the effectiveness of repeated injections of onabotulinum toxin A for refractory idiopathic detrusor overactivity: analysis of an open label extension of a randomized trial (the RELAX study).Application of ICHD-II criteria for headaches in a TMJ and orofacial pain clinic.Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.The Expanding Therapeutic Utility of Botulinum Neurotoxins.Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine.Botulinum Toxin in Headache Treatment: The End of the Road?
P2860
Q26781281-304A0111-DF35-42E7-B54C-E2203D16A2E9Q26796286-31D43231-BA73-452A-BD54-86D7D15715BEQ26799317-7234797F-FF8F-43D4-967E-A346B2FE859EQ27027006-CACBBDE8-1995-4125-BCFE-D09D9CA94BD1Q34025381-088A1231-1493-422B-892A-21974DF4CDC0Q34760355-BBB4C84A-3FBA-41EC-8BA0-F62B68D411F8Q34813721-B52D6610-5B1D-4E8E-B49E-C815795FD832Q35113553-C0E23362-9326-490E-B725-3A0BF1138E17Q35822040-DBE6776A-F658-4F53-AD47-429E91E78498Q36239508-CDF9A9A5-5C3F-46A2-962A-CBB028641F16Q36332480-40D6E6E2-C34E-49B0-B318-56942168EAB5Q36580576-41C08AF0-5DEB-4CEF-9230-DB9903DAF679Q36600278-FACD9F91-90E4-4A31-BF12-E9BFECD20C5EQ36947170-773AF2F4-1B53-4A9A-97F0-FD2FBD869621Q37418971-1B4CDDDE-E93F-45A6-933E-82C82FA3718FQ37492582-5D0629BD-5702-4454-AD50-F903305E7BACQ37699425-2A3DEF63-EA93-4779-A44E-279F5840BF68Q37703847-B4B64F9D-E870-4543-A5CC-BA4C893B8198Q37809775-8245836E-05EA-4886-8EB3-85A65A40BC54Q37940623-2CB0984D-1F4C-4F17-9B1F-608A2952D8B7Q37955981-80CA4414-E84A-425B-9297-780C6CF701A2Q37987990-4016D39B-5540-4CE8-AF99-1790F2F1D95AQ38031982-7808A2A3-F78E-472E-B582-F77536AECBB8Q38254097-206FF587-3E9B-4D3E-B7E1-DF7A4B7E3691Q38270470-14380735-66F4-4F35-8376-1E511AE5336FQ41849757-0B230506-35B4-49CC-B394-9F9877EA5164Q42370565-86E0BE95-50FD-49AB-BF83-2E083974F411Q42373798-4CA850FF-13E9-4F40-8533-5A8032C86184Q48348149-4B73A78C-307E-43FC-8B8B-FA2C3ED2EC53Q51548888-16F1F24D-11B7-4687-B43F-2B58B1A076D2Q51639026-784AB5EB-0B95-4C41-B5A3-898A3C2704A1Q53407201-BABDB6C2-8FF9-4B69-A757-36F5FC0C94A6Q55105284-EF7C12FB-4A28-4C35-A8E2-7A9EF543E950Q55515282-2EE65B5E-D5D1-4036-9ED1-6F71A44E5CE7Q57024415-3D46C1D7-05A5-4EFE-9D05-AB23C944F89A
P2860
Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Botulinum toxin type A in the ...... trolled, parallel-group study.
@en
Botulinum toxin type A in the ...... trolled, parallel-group study.
@nl
type
label
Botulinum toxin type A in the ...... trolled, parallel-group study.
@en
Botulinum toxin type A in the ...... trolled, parallel-group study.
@nl
prefLabel
Botulinum toxin type A in the ...... trolled, parallel-group study.
@en
Botulinum toxin type A in the ...... trolled, parallel-group study.
@nl
P2093
P2860
P1433
P1476
Botulinum toxin type A in the ...... trolled, parallel-group study.
@en
P2093
Silberstein SD
Walcott JM
P2860
P304
P356
10.1111/J.1468-2982.2006.01114.X
P407
P577
2006-07-01T00:00:00Z